Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

The Mechanisms of CD8+ T Cells in Kidney Injury

  1. 1Graduate School, Hebei University of Chinese Medicine, Shijiazhuang 050091, China
  2. 2College of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050091, China
  3. 3Hebei Key Laboratory of Integrative Medicine on Liver-Kidney Patterns, Shijiazhuang 050091, China

Abstract

Kidney injury encompasses a range of pathological conditions including acute kidney injury (AKI), chronic kidney disease (CKD), and the transition from AKI to CKD. Given its multifactorial pathogenesis, dismal clinical outcomes, and the paucity of effective targeted therapies, renal injury constitutes a substantial global public health burden. As a core effector of adaptive immunity, CD8+ T cells not only participate in the body’s anti-infection and anti-tumor immune responses, but are also involved throughout the process of kidney injury. Emerging technologies such as single-cell sequencing and immune gene editing are now revealing the bidirectional roles and subset diversity of CD8+ T cells in renal injury. Accumulating evidence suggests that CD8+ T cells may contribute to kidney injury progression in specific experimental and clinical contexts via diverse mechanisms, including direct cytotoxicity against renal parenchymal cells, secretion of pro-inflammatory and pro-fibrotic mediators, remodeling of the local immune microenvironment, and induction of microvascular damage. Meanwhile, their regulatory subsets curb overt inflammation, retard fibrosis, and preserve renal function. This review surveys the biology and subset heterogeneity of CD8+ T cells, recapitulates their involvement in AKI, CKD, and disease transition, evaluates targeted immunotherapies and translational progress, and highlights unresolved issues and future priorities, with the goal of informing mechanistic studies and precision management of renal injury.

Related

  1. Disulfidptosis, Hydrogen Sulfide, and Acute Kidney Injury: Emerging Mechanisms and Therapeutic Intersections
    Shreyasi Gupta, Subhadeep Mandal, Kalyan Banerjee +3
    BiomoleculesPeer-reviewedCC BYFull textGeneral biochemistryMicrobiologyEurope PMCDOAJ
  2. Mitochondrial Injury and Inflammation–Fibrosis Coupling in Diabetic Kidney Disease: Cell Type-Specific Mechanisms and Therapeutic Implications
    Weichen Nie, Zihan Wang, Lu Ding +6
    BiomoleculesPeer-reviewedCC BY 4.0General biochemistryCrossref
  3. Extracellular Vesicles from Human Induced Pluripotent Stem Cells Reduce Lung Ischemia-Reperfusion Injury via Cytoprotective Mechanisms in both 2D Cultures and a Human Airway Organoid Model.
    Rosaria Tinnirello, Maria Chiara Iachini, Maura Cimino +20
    International journal of biological sciencesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  4. Proteomic Evaluation of the Progression from Acute Kidney Injury to Chronic Kidney Disease
    S. Sims-Lucas, J. Bons, K. E. Pfister +4
    bioRxivPreprintAll rights reservedFull textGeneral biochemistrybioRxiv
  5. Flow Cytometry and AI-Driven Biomarker Discovery in Acute Kidney Injury: From Mechanistic Insights to Translation Applications in Clinical and Austere Environments
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
BibTeX
@article{an2026mechanisms,
  title = {{The Mechanisms of CD8+ T Cells in Kidney Injury}},
  author = {Jingwen An and Fengrui Liu and Jianing Lu and Chang Xu and Nan Zhai and Ruyan Lv and Yuanchun Chen and Wenjing Li and Yuanyuan Zhao and Yan Zhong and Xiangting Wang},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = nov,
  doi = {10.3390/ijms272210265},
  url = {https://www.mdpi.com/1422-0067/27/22/10265},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - The Mechanisms of CD8+ T Cells in Kidney Injury
AU  - Jingwen An
AU  - Fengrui Liu
AU  - Jianing Lu
AU  - Chang Xu
AU  - Nan Zhai
AU  - Ruyan Lv
AU  - Yuanchun Chen
AU  - Wenjing Li
AU  - Yuanyuan Zhao
AU  - Yan Zhong
AU  - Xiangting Wang
PY  - 2026
DA  - 2026/11/16
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms272210265
UR  - https://www.mdpi.com/1422-0067/27/22/10265
AB  - Kidney injury encompasses a range of pathological conditions including acute kidney injury (AKI), chronic kidney disease (CKD), and the transition from AKI to CKD. Given its multifactorial pathogenesis, dismal clinical outcomes, and the paucity of effective targeted therapies, renal injury constitutes a substantial global public health burden. As a core effector of adaptive immunity, CD8+ T cells not only participate in the body’s anti-infection and anti-tumor immune responses, but are also involved throughout the process of kidney injury. Emerging technologies such as single-cell sequencing and immune gene editing are now revealing the bidirectional roles and subset diversity of CD8+ T cells in renal injury. Accumulating evidence suggests that CD8+ T cells may contribute to kidney injury progression in specific experimental and clinical contexts via diverse mechanisms, including direct cytotoxicity against renal parenchymal cells, secretion of pro-inflammatory and pro-fibrotic mediators, remodeling of the local immune microenvironment, and induction of microvascular damage. Meanwhile, their regulatory subsets curb overt inflammation, retard fibrosis, and preserve renal function. This review surveys the biology and subset heterogeneity of CD8+ T cells, recapitulates their involvement in AKI, CKD, and disease transition, evaluates targeted immunotherapies and translational progress, and highlights unresolved issues and future priorities, with the goal of informing mechanistic studies and precision management of renal injury.
SN  - 1422-0067
ER  -